Mostrar el registro sencillo del ítem

dc.contributor.authorFernández, Jose Javier
dc.contributor.authorMarín, Arturo
dc.contributor.authorRosales, Romel
dc.contributor.authorPenrice-Randal, Rebekah
dc.contributor.authorMlcochova, Petra
dc.contributor.authorAlvarez, Yolanda
dc.contributor.authorVillalón-Letelier, Fernando
dc.contributor.authorYildiz, Soner
dc.contributor.authorPérez, Enrique
dc.contributor.authorRathnasinghe, Raveen
dc.contributor.authorCupic, Anastasija
dc.contributor.authorKehrer, Thomas
dc.contributor.authorB Uccellini, Melissa
dc.contributor.authorAlonso, Sara
dc.contributor.authorMartínez, Fernando
dc.contributor.authorLynn McGovern, Briana
dc.contributor.authorJ Clark, Jordan
dc.contributor.authorSharma, Parul
dc.contributor.authorBayón Prieto, Yolanda 
dc.contributor.authorAlonso, Andrés
dc.contributor.authorA Albrecht, Randy
dc.contributor.authorM White, Kris
dc.contributor.authorSchotsaert, Michael
dc.contributor.authorMiorin, Lisa
dc.contributor.authorP Stewart, James
dc.contributor.authorA Hiscox, Julian
dc.contributor.authorK Gupta, Ravindra
dc.contributor.authorIrigoyen, Nerea
dc.contributor.authorGarcía-Sastre, Adolfo
dc.contributor.authorSánchez Crespo, Mariano
dc.contributor.authorFernández, Nieves
dc.date.accessioned2025-01-15T10:16:18Z
dc.date.available2025-01-15T10:16:18Z
dc.date.issued2024
dc.identifier.citationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Volume 1870, Issue 5, June 2024, 167193es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/73859
dc.descriptionProducción Científicaes
dc.description.abstractSARS-CoV-2 infection can cause severe pneumonia, wherein exacerbated inflammation plays a major role. This is reminiscent of the process commonly termed cytokine storm, a condition dependent on a disproportionated production of cytokines. This state involves the activation of the innate immune response by viral patterns and coincides with the biosynthesis of the biomass required for viral replication, which may overwhelm the capacity of the endoplasmic reticulum and drive the unfolded protein response (UPR). The UPR is a signal transduction pathway composed of three branches that is initiated by a set of sensors: inositol-requiring protein 1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor 6 (ATF6). These sensors control adaptive processes, including the transcriptional regulation of proinflammatory cytokines. Based on this background, the role of the UPR in SARS-CoV-2 replication and the ensuing inflammatory response was investigated using in vivo and in vitro models of infection. Mice and Syrian hamsters infected with SARS-CoV-2 showed a sole activation of the Ire1α-Xbp1 arm of the UPR associated with a robust production of proinflammatory cytokines. Human lung epithelial cells showed the dependence of viral replication on the expression of UPR-target proteins branching on the IRE1α-XBP1 arm and to a lower extent on the PERK route. Likewise, activation of the IRE1α-XBP1 branch by Spike (S) proteins from different variants of concern was a uniform finding. These results show that the IRE1α-XBP1 system enhances viral replication and cytokine expression and may represent a potential therapeutic target in SARS-CoV-2 severe pneumonia.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherElsevieres
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectBiomedicinaes
dc.subject.classificationCOVID-19 Cytokines Fluvoxamine Pneumonia TLR Transcription factors Unfolded protein response Viral sepsis Variants of concernes
dc.titleThe IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infectiones
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doidoi: 10.1016/j.bbadis.2024.167193es
dc.relation.publisherversionhttps://doi.org/10.1016/j.bbadis.2024.167193es
dc.identifier.publicationfirstpage167193es
dc.identifier.publicationissue1870es
dc.identifier.publicationtitleThe IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infectiones
dc.identifier.publicationvolumeIssue 5es
dc.peerreviewedSIes
dc.description.projectJunta de Castilla y León/Fondo Social Europeo Grants CSI035P17 and VA175P20es
dc.description.projectPlan Nacional de Salud y Farmacia Grant SAF2017-83079-R and Grant PID2020-113751RB-I00 funded by MCIN/AEI/ 10.13039/501100011033es
dc.description.projectEuropean Commission-NextGenerationEU, (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global)es
dc.description.projectWellcome Trust Senior Fellowship in Clinical Science (WT108082AIA)es
dc.description.projectFondo COVID-19 del Instituto de Salud Carlos III/Junta de Castilla y Leónes
dc.description.projectU.S. Food and Drug Administration Medical Countermeasures Initiative contract (75F40120C00085)es
dc.description.projectG2P-UK: A national virology consortium to address phenotypic consequences of SARS-CoV-2 genomic variationes
dc.description.projectNational Institutes of Health (NIH) grant: R21AI147172 (N.I.), NIH/NIAID R01AI160706, NIH/NIAID R21AI176069, and NIH/NIDDK R01DK130425es
dc.description.projectThis work was also partly supported by NIAID grant U19AI135972, and by CRIPT (Center for Research on Influenza Pathogenesis and Transmission), a NIAID funded Center of Excellence for Influenza Research and Response (CEIRR, contract # 75N93021C00014) (A.G.S.). This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai and supported by the Clinical and Translational Science Awards (CTSA) grant UL1TR004419 from the National Center for Advancing Translational Sciences.es
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco24 Ciencias de la Vidaes


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem